Medicare Enrolled
Dr. Shilpa Sambidi, M.D.
Hematology & Oncology · Johnson City, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sambidi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sambidi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sambidi
Dr. Shilpa Sambidi is a hematology & oncology specialist in Johnson City, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sambidi performed 53,447 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sambidi received a total of $6,642 from 60 pharmaceutical and/or device companies across 412 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sambidi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 12% volume in NY
$6,642 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗53,447
Medicare services
Top 12% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
18,000 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 10,200 | $43 | $159 |
| Anti-nausea injection (aprepitant) | 4,810 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,960 | $18 | $67 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,049 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,700 | $6 | $26 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,680 | $6 | $27 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,280 | $1 | $4 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,147 | $8 | $75 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,076 | $8 | $100 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
856 | $10 | $100 |
| Anti-nausea injection (ondansetron/Zofran) | 728 | $0 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
691 | $92 | $319 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
589 | $72 | $521 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
468 | $12 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
442 | $60 | $202 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
348 | $88 | $445 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
326 | $99 | $500 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
251 | $11 | $100 |
| Injection, potassium chloride, per 2 meq | 200 | $0 | $2 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
197 | $55 | $300 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
174 | $7 | $75 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
110 | $2 | $9 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
107 | $22 | $150 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
103 | $49 | $175 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
90 | $10 | $100 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
76 | $1 | $1 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
68 | $25 | $300 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
56 | $1 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
55 | $47 | $250 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
53 | $6 | $100 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
50 | $43 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $128 | $358 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
45 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
44 | $22 | $150 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
42 | $14 | $100 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
40 | $25 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $116 | $437 |
| New patient office visit, complex (60-74 min) | 34 | $156 | $542 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
33 | $8 | $100 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
33 | $17 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $62 | $166 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
31 | $74 | $350 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $29 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $125 | $460 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $101 | $312 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $30 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
34.9% high complexity
56.0% medium
9.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,642
Total received (2018-2024)
Avg $949/year across 7 years
Top 31% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
412
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,328
2023
$2,100
2022
$982
2021
$694
2020
$185
2019
$726
2018
$626
Payments by company (2024)
PFIZER INC.
$264
ABBVIE INC.
$169
E.R. Squibb & Sons, L.L.C.
$150
Novartis Pharmaceuticals Corporation
$84
GENZYME CORPORATION
$74
GlaxoSmithKline, LLC.
$73
Celgene Corporation
$68
Daiichi Sankyo Inc.
$63
AstraZeneca Pharmaceuticals LP
$56
PharmaEssentia USA Corporation
$51
Eisai Inc.
$43
Blueprint Medicines Corporation
$32
Regeneron Healthcare Solutions, Inc.
$31
Myriad Genetic Laboratories, Inc.
$29
Gilead Sciences, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Ipsen Biopharmaceuticals, Inc
$22
Alnylam Pharmaceuticals Inc.
$21
Genmab U.S., Inc.
$20
TAIHO ONCOLOGY, INC.
$17
ADC Therapeutics America, Inc.
$15
Top 3 companies account for 43.9% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$713
E.R. Squibb & Sons, L.L.C.
$606
Janssen Biotech, Inc.
$582
Novartis Pharmaceuticals Corporation
$500
Genentech USA, Inc.
$394
Pharmacyclics LLC, An AbbVie Company
$299
Seagen Inc.
$294
GENZYME CORPORATION
$220
GlaxoSmithKline, LLC.
$189
EMD Serono, Inc.
$189
Celgene Corporation
$183
AstraZeneca Pharmaceuticals LP
$174
ABBVIE INC.
$169
Takeda Pharmaceuticals U.S.A., Inc.
$150
Daiichi Sankyo Inc.
$138
Amgen Inc.
$121
Merck Sharp & Dohme Corporation
$116
Eisai Inc.
$107
Astellas Pharma US Inc
$83
ARRAY BIOPHARMA INC
$76
Gilead Sciences, Inc.
$74
Ipsen Biopharmaceuticals, Inc
$71
EISAI INC.
$58
Epizyme, Inc.,
$55
TerSera Therapeutics LLC
$54
AbbVie Inc.
$54
Lilly USA, LLC
$53
BeiGene USA, Inc.
$51
PharmaEssentia USA Corporation
$51
Apellis Pharmaceuticals, Inc.
$49
Blueprint Medicines Corporation
$47
Regeneron Healthcare Solutions, Inc.
$44
CTI BioPharma Corp.
$40
EAGLE PHARMACEUTICALS, INC.
$40
Alexion Pharmaceuticals, Inc.
$39
Sumitomo Pharma America, Inc.
$37
Puma Biotechnology, Inc.
$37
Merck Sharp & Dohme LLC
$36
Pharmacosmos Therapeutics Inc.
$36
TAIHO ONCOLOGY, INC.
$33
Incyte Corporation
$32
Myriad Genetic Laboratories, Inc.
$29
EUSA Pharma (US) LLC
$28
Kyowa Kirin, Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
Mirati Therapeutics, Inc.
$21
Alnylam Pharmaceuticals Inc.
$21
Genmab U.S., Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Sobi, Inc
$19
Deciphera Pharmaceuticals Inc.
$17
Rigel Pharmaceuticals, Inc.
$17
Stemline Therapeutics Inc.
$16
SERVIER PHARMACEUTICALS LLC
$15
SOBI, INC
$15
AbbVie, Inc.
$15
ADC Therapeutics America, Inc.
$15
Advanced Accelerator Applications
$14
Myovant Sciences Inc.
$13
Exelixis Inc.
$11
Top 3 companies account for 28.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ADVATE · AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Erivedge · Erleada · FARESTON · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LARTRUVO · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nplate · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMFEXY · PIQRAY · POTELIGEO · PROMACTA · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYDAPT · Rezlidhia · SARCLISA · SOLIRIS · SOMATULINE DEPOT · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Vonjo · XALKORI · XTANDI · XYNTHA · Xermelo · Xtandi · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
8
County median income
$61,059
Nearest hospital to ZIP centroid (approximate)
OUR LADY OF LOURDES MEMORIAL HOSPITAL, INC
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sambidi is a mixed practice specialist, with above-average Medicare volume (top 12% in NY), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sambidi experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Sambidi performed 18,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sambidi receive payments from pharmaceutical companies?
Yes. Dr. Sambidi received a total of $6,642 from 60 companies across 412 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sambidi's costs compare to other hematology & oncology specialists in Johnson City?
Dr. Sambidi's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sambidi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Johnson City
Browse hematology & oncology specialists in Johnson City ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology